141 related articles for article (PubMed ID: 2180699)
1. Carboxyl-terminal structure of basic fibroblast growth factor significantly contributes to its affinity for heparin.
Seno M; Sasada R; Kurokawa T; Igarashi K
Eur J Biochem; 1990 Mar; 188(2):239-45. PubMed ID: 2180699
[TBL] [Abstract][Full Text] [Related]
2. Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization.
Pantoliano MW; Horlick RA; Springer BA; Van Dyk DE; Tobery T; Wetmore DR; Lear JD; Nahapetian AT; Bradley JD; Sisk WP
Biochemistry; 1994 Aug; 33(34):10229-48. PubMed ID: 7520751
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the heparin-binding domains of human basic fibroblast growth factor alter its biological activity.
Heath WF; Cantrell AS; Mayne NG; Jaskunas SR
Biochemistry; 1991 Jun; 30(22):5608-15. PubMed ID: 2036431
[TBL] [Abstract][Full Text] [Related]
4. Carboxyl-terminal heparin-binding fragments of platelet factor 4 retain the blocking effect on the receptor binding of basic fibroblast growth factor.
Sato Y; Waki M; Ohno M; Kuwano M; Sakata T
Jpn J Cancer Res; 1993 May; 84(5):485-8. PubMed ID: 8320164
[TBL] [Abstract][Full Text] [Related]
5. Stabilizing basic fibroblast growth factor using protein engineering.
Seno M; Sasada R; Iwane M; Sudo K; Kurokawa T; Ito K; Igarashi K
Biochem Biophys Res Commun; 1988 Mar; 151(2):701-8. PubMed ID: 2831901
[TBL] [Abstract][Full Text] [Related]
6. Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain.
Thompson LD; Pantoliano MW; Springer BA
Biochemistry; 1994 Apr; 33(13):3831-40. PubMed ID: 8142385
[TBL] [Abstract][Full Text] [Related]
7. Characterization of high-molecular-mass forms of basic fibroblast growth factor produced by hepatocellular carcinoma cells: possible involvement of basic fibroblast growth factor in hepatocarcinogenesis.
Shimoyama Y; Gotoh M; Ino Y; Sakamoto M; Kato K; Hirohashi S
Jpn J Cancer Res; 1991 Nov; 82(11):1263-70. PubMed ID: 1721615
[TBL] [Abstract][Full Text] [Related]
8. Structure-function relationship of basic fibroblast growth factor: site-directed mutagenesis of a putative heparin-binding and receptor-binding region.
Presta M; Statuto M; Isacchi A; Caccia P; Pozzi A; Gualandris A; Rusnati M; Bergonzoni L; Sarmientos P
Biochem Biophys Res Commun; 1992 Jun; 185(3):1098-107. PubMed ID: 1378264
[TBL] [Abstract][Full Text] [Related]
9. Disulfide structure of the heparin binding domain in vascular endothelial growth factor: characterization of posttranslational modifications in VEGF.
Keck RG; Berleau L; Harris R; Keyt BA
Arch Biochem Biophys; 1997 Aug; 344(1):103-13. PubMed ID: 9244387
[TBL] [Abstract][Full Text] [Related]
10. Cleavage of K-FGF produces a truncated molecule with increased biological activity and receptor binding affinity.
Bellosta P; Talarico D; Rogers D; Basilico C
J Cell Biol; 1993 May; 121(3):705-13. PubMed ID: 8387532
[TBL] [Abstract][Full Text] [Related]
11. Potent 2'-amino-2'-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor.
Jellinek D; Green LS; Bell C; Lynott CK; Gill N; Vargeese C; Kirschenheuter G; McGee DP; Abesinghe P; Pieken WA
Biochemistry; 1995 Sep; 34(36):11363-72. PubMed ID: 7547864
[TBL] [Abstract][Full Text] [Related]
12. Expression of cDNA encoding human basic fibroblast growth factor in E. coli.
Iwane M; Kurokawa T; Sasada R; Seno M; Nakagawa S; Igarashi K
Biochem Biophys Res Commun; 1987 Jul; 146(2):470-7. PubMed ID: 3304281
[TBL] [Abstract][Full Text] [Related]
13. The heparin-binding domain of extracellular superoxide dismutase C and formation of variants with reduced heparin affinity.
Sandström J; Carlsson L; Marklund SL; Edlund T
J Biol Chem; 1992 Sep; 267(25):18205-9. PubMed ID: 1517248
[TBL] [Abstract][Full Text] [Related]
14. Alternative splicing determines the binding of platelet-derived growth factor (PDGF-AA) to glycosaminoglycans.
Lustig F; Hoebeke J; Ostergren-Lundèn G; Velge-Roussel F; Bondjers G; Olsson U; Rüetschi U; Fager G
Biochemistry; 1996 Sep; 35(37):12077-85. PubMed ID: 8810913
[TBL] [Abstract][Full Text] [Related]
15. Biochemical bases of the interaction of human basic fibroblast growth factor with glycosaminoglycans. New insights from trypsin digestion studies.
Coltrini D; Rusnati M; Zoppetti G; Oreste P; Isacchi A; Caccia P; Bergonzoni L; Presta M
Eur J Biochem; 1993 May; 214(1):51-8. PubMed ID: 8508806
[TBL] [Abstract][Full Text] [Related]
16. Glu-96 of basic fibroblast growth factor is essential for high affinity receptor binding. Identification by structure-based site-directed mutagenesis.
Zhu H; Ramnarayan K; Anchin J; Miao WY; Sereno A; Millman L; Zheng J; Balaji VN; Wolff ME
J Biol Chem; 1995 Sep; 270(37):21869-74. PubMed ID: 7665610
[TBL] [Abstract][Full Text] [Related]
17. An amino-terminally extended and post-translationally modified form of a 25kD basic fibroblast growth factor.
Sommer A; Moscatelli D; Rifkin DB
Biochem Biophys Res Commun; 1989 May; 160(3):1267-74. PubMed ID: 2730645
[TBL] [Abstract][Full Text] [Related]
18. Neutralizing antibodies inhibit the binding of basic fibroblast growth factor to its receptor but not to heparin.
Kurokawa M; Doctrow SR; Klagsbrun M
J Biol Chem; 1989 May; 264(13):7686-91. PubMed ID: 2540201
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between biological activity and heparin-affinity sites of recombinant human basic fibroblast growth factor CS23 mutein].
Hiroshima T; Higashi A; Kusumoto S; Nishi K; Nishijima K
Yakugaku Zasshi; 1999 May; 119(5):401-9. PubMed ID: 10376000
[TBL] [Abstract][Full Text] [Related]
20. The heparin binding site of human extracellular-superoxide dismutase.
Adachi T; Kodera T; Ohta H; Hayashi K; Hirano K
Arch Biochem Biophys; 1992 Aug; 297(1):155-61. PubMed ID: 1637178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
